Brief: ALX Oncology Q1 loss from operations USD 32.203 million
11/05/2023 21:23
May 11 (Reuters) - ALX Oncology Q1 operating expenses USD 32.203 million. * Q1 net income USD -30.184 million * Q1 basic EPS USD -0.74 * Q1 income from operations USD -32.203 million
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing